EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human

Carrie Hayes Sutter1, Hong Yin, Yunbo Li

  • 1Department of Biology and W. Harry Feinstone Center for Genomic Research, University of Memphis, Memphis, TN 38152-3560, USA.

Insights

Dioxin exposure disrupts skin homeostasis by activating the aryl hydrocarbon receptor (AHR), leading to accelerated keratinocyte differentiation. Epidermal Growth Factor Receptor (EGFR) signaling opposes this, revealing a potential therapeutic target for dioxin toxicity and chloracne.

Area of Science:

  • Toxicology
  • Dermatology
  • Molecular Biology

Background:

  • Dioxins are potent carcinogens causing chloracne via aryl hydrocarbon receptor (AHR) activation.
  • AHR, with ARNT, regulates genes crucial for skin barrier function.
  • Epidermal Growth Factor Receptor (EGFR) signaling controls keratinocyte fate.

Purpose of the Study:

  • To investigate the mechanism of dioxin-induced keratinocyte differentiation.
  • To explore the role of EGFR signaling in modulating AHR activity.
  • To understand the molecular basis of dioxin's effects on skin homeostasis.

Main Methods:

  • Studied dioxin's effects on human epidermal keratinocytes in culture.
  • Investigated gene expression regulated by AHR and ARNT.
  • Examined the interaction between AHR and EGFR signaling pathways.
  • Assessed the role of p300 coactivator in EGFR-mediated repression.

Main Results:

  • Dioxin accelerates keratinocyte differentiation via AHR.
  • EGFR activation opposes dioxin's effects on gene expression and differentiation.
  • EGFR signaling inhibits AHR/ARNT transcriptional activity by preventing p300 coactivator recruitment.
  • Overexpression of p300 rescues EGFR-mediated repression.

Conclusions:

  • Dioxin disrupts epidermal homeostasis through AHR activation.
  • EGFR signaling acts as a negative regulator of the AHR pathway.
  • EGFR's modulation of AHR offers therapeutic insights for dioxin poisoning and chloracne.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...